The presence of oestrogen receptors (ER) in normal target tissues such as breast or uterine epithelium is generally accepted as a marker for oestrogenic regulation of their growth and activity. Likewise, the presence of oestrogen receptors in malignant mammary tissue is believed to indicate the potential oestrogenic regulation of the cancer. Although cytosolic oestrogen receptors are used as a guide to the selection of those patients with advanced disease who might benefit from endocrine manipulative therapy, their presence is associated with a reponse to endocrine therapy in only 50-60% of patients (Hawkins et al., 1980) . In an effort to explain this, and perhaps also improve selection of these patients, the association between oestrogen receptors and a variety of other biological parameters has been investigated, e.g. cell cycle kinetics (Meyer et al., 1984) , histological tumour typing and grading (Howat et al., 1983; Mossler et al., 1980; Underwood, 1983) and nuclear ploidy. In general, these studies have shown that variables associated with poor prognosis in breast cancer appear to be associated more frequently with an absence of oestrogen receptors. While the presence of aneuploid tumour nuclei has been linked to poor prognosis (Atkin, 1972; Auer et al., 1984) , an association with oestrogen receptor content has not been conclusively established (Auer et al., 1980; Bichel, et al., 1982; Cornelisse et al., 1984 al., Olszewski et al., 1981; Raber et al., 1982; Taylor et al., 1983) . One of these studies (Bichel et al., 1982) suggested that aneuploidy might be responsible for the lack of endocrine responsiveness which occurs in 40% of ER positive tumours.
In this study we have examined the relationship between the presence of aneuploid nuclei and oestrogen receptors in a large group of primary invasive breast cancers. This relationship was examined for both the entire tumour population and the ductal carcinomas. In addition, using the presence of progesterone receptors (PR) DNA analysis of biopsy cell nuclei Tumour biopsy specimens were sliced in ice-cold medium RPMI 1640 into 1-2mm fragments, using scalpels. The cells which spilled out were then sieved from the residual fragments through 250,im stainless steel mesh, centrifuged and resuspended to 2 x l06 ml-1 in RPMI plus I mg ml -1 RNase. A biological internal standard (chicken RBC) was used to control both instrument and staining variability during flow cytometry. The marker chicken RBC were added to the tumour cell suspension to a final concentration of 1.5 x 1 05ml -1. Cell nuclei were then prepared and stained, by the addition of a half-volume aliquot of ethidium bromide (0.3 mgml-1) in 0.8% (v/v) Triton X100 (Taylor & Milthorpe, 1980) . After mixing, the nuclei were allowed to remain at room temperature for 5 min, and then sieved through 50pm mesh. DNA analysis was carried out using a Becton Dickinson FACS IV flow cytometer with With the lobular carcinomas, no significant difference in the distribution of either receptor type could be found.
Separation of the infiltrating ductal carcinomas into the NOS and specific variant groups (Table  III) , demonstrated a statistical association between aneuploidy and an absence of oestrogen receptors only for the specific variant group (P= 0.025).
Similar associations were investigated for a combined receptor status. The absence of both receptors (ER-PR-) was found to be significantly associated with the presence of aneuploid nuclei in the entire tumour group (P<0.001), the total infiltrating ductal and the NOS subgroups (P<0.01), and the ductal variant subgroup (P<0.05) (Tables  II and III) . (Table IV) , no significant differences were seen for either the whole tumour population or for each histological subclass.
Discussion
The proportion of aneuploid tumours in this study (57%) is in agreement with previously published values for primary breast cancer (for review, see Meyer et al., 1984) . Similarly, the incidence of ER in the overall tumour population (70%) is in agreement with the generally accepted value (Hawkins et al., 1980) . The incidence of ER in the individual histological types also compare favourably with those reviewed by Underwood (1983) . Variations in reported incidences of aneuploidy and hormone receptors for primary breast cancer may be due to intra-tumour heterogeneity.
Analysis of a small fragment of tumour in isolation might not yield a representative determination. This problem has been addressed for both hormone receptor content (Tilley et al., 1978) and ploidy determination (Thornthwaite et al., 1980) , and is usually overcome as in this study by analysis of several fragments of tumour obtained from various sites in the biopsy. Certain tissue dissociation methods may also result in cell suspensions qualitatively unrepresentative of the original biopsy composition. For example, we have observed similar results to those of Chassevent et al. (1984) , where enzymatic dissociation appeared to selectively reduce the aneuploid cell populations in the resulting cell suspension (manuscript in preparation). Consequently enzymatic dispersion of solid tumours was not used in this study.
The presence of aneuploid nuclei and oestrogen receptors appear to be opposing prognostic indicators in relation to disease course and survival prospects in breast cancer (Atkin, 1972; Auer et al., 1984; Hawkins et al., 1980) . A statistically significant association between the presence of aneuploid tumour nuclei and the absence of ER is apparent from some studies (Auer et al., 1980;  Bichel et al., 1982; Olszewski et al., 1981) , but in others only a trend was observed (Cornelisse et al., 1984; Kute et al., 1981; Raber et al., 1982; Taylor et al., 1983) . We were thus prompted to re-examine this association. Our results confirm that an association between the presence of aneuploidy and the absence of oestrogen receptors does exist as reported. A statistically significant association was observed for the entire population of tumours, the total ductal carcinoma group, and for the specific ductal variant group. Trends towards a similar association were seen for the ductal NOS tumours and for the lobular carcinomas, but statistical significance was not reached in either case. The low number of tumours was possibly a contributing factor for the lobular carcinoma group.
Little has been reported on the association between aneuploidy and the existence of progesterone receptors. Meyer et al. (1984) noted a tendency for diploid carcinomas to be PR positive more frequently than aneuploid carcinomas, but statistical significance was not reached. Kute et al. (1981) , using small numbers of mixed primary and metastatic patients, was also unable to demonstrate any statistical difference. In this study a statistically significant association was shown to exist between aneuploidy and the absence of progesterone receptors for the total tumour population.
Combination of the receptor markers reinforces the associations seen between aneuploidy and oestrogen and progesterone receptors, with the result that the likelihood of tumours devoid of both oestrogen and progesterone receptors being aneuploid is extremely high (P<0.001). The analysis of combined receptor status revealed data (Tables II and III) Hawkins et al., 1980) . The presence of both oestrogen and progesterone receptors is a useful clinical index of patient response to endocrine therapy. In this study we have shown that the converse (i.e. the absence of both receptors) is strongly associated with the presence of aneuploid nuclei. In the past, aneuploid nuclei and the absence of hormone receptors have been considered to be independent indicators of poor prognosis, but this study indicates that a strong association exists between these parameters.
The existence of a population of ER positive tumours with aneuploid nuclei prompted Bichel et al. (1982) to suggest that this population might correspond to those ER positive tumours which do not respond to endocrine therapy. This study indirectly examined that proposal by using the expression of progesterone receptors as a marker of an intact oestrogenic regulatory system. Progesterone receptors have been shown to be regulated by oestrogen in both uterine tissues (Janne et al., 1975; Kassis et al., 1984) and breast cancer cell lines (Horwitz & McGuire, 1978) . In this study progesterone receptors were found in 75% of ER positive tumours with no statistical difference in the distribution between diploid and aneuploid tumours. Therefore, we conclude that aneuploidy appears unlikely to alter the biological activity of oestrogen receptors. A speculative interpretation of this data is that the initial response rate to endocrine therapy might be expected to be similar in patients with diploid or aneuploid ER positive breast cancer. Evaluation of the influence of aneuploidy on the ultimate outcome of hormonal therapy for ER positive breast cancers is currently in progress in our laboratory.
In conclusion, this study has demonstrated statistically significant associations between the presence of aneuploid nuclei in breast cancer and the absence of cytosolic oestrogen and progesterone receptors. However, the similarity in distribution of progesterone receptor binding activity in diploid and aneuploid ER positive tumours observed in the present study suggests that the variable response of ER positive tumours to endocrine therapy is attributable to factors other than aneuploidy.
